![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
2026-05-12
克服传统联用局限:共载帕布昔利布与氟维司群的阳离子脂质体用于乳腺癌治疗
2026-05-12
用于心肌细胞的高效递送系统:心肌靶向肽(PCM)和穿膜肽(TAT)双修饰脂质体
2026-05-12
双效协同止血:纤维蛋白原γ链靶向与二磷酸腺苷(ADP)释放联用的仿生脂质体
2026-05-12
热疗增强肿瘤靶向:热敏性类弹性蛋白多肽(ELPs)修饰脂质体用于智能递送阿霉素
2026-04-29
抗肝素(Hep)肽(AG73肽)修饰PEG(聚乙二醇)化脂质体递送依地福新用于癌细胞选择性给药
2026-04-29
协同抑制转移:R8肽修饰脂质体共递送表柔比星与二氢青蒿素增强抗肺癌疗效